SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Top Cited Papers
- 1 November 2020
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 183 (4), 1043-1057.e15
- https://doi.org/10.1016/j.cell.2020.09.033
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
- National Science Foundation
This publication has 61 references indexed in Scilit:
- RELION: Implementation of a Bayesian approach to cryo-EM structure determinationJournal of Structural Biology, 2012
- Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate ProteoglycansPLOS ONE, 2011
- A Comprehensive Compositional Analysis of Heparin/Heparan Sulfate-Derived Disaccharides from Human SerumAnalytical Chemistry, 2011
- Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccinesJournal of Virological Methods, 2010
- DoG Picker and TiltPicker: Software tools to facilitate particle selection in single particle electron microscopyJournal of Structural Biology, 2009
- Appion: An integrated, database-driven pipeline to facilitate EM image processingJournal of Structural Biology, 2009
- Evolutionary Differences in Glycosaminoglycan Fine Structure Detected by Quantitative Glycan Reductive Isotope LabelingOnline Journal of Public Health Informatics, 2008
- Human Follicular Fluid Heparan Sulfate Contains Abundant 3-O-Sulfated Chains with Anticoagulant ActivityOnline Journal of Public Health Informatics, 2008
- The war against influenza: discovery and development of sialidase inhibitorsNature Reviews Drug Discovery, 2007
- Automated molecular microscopy: The new Leginon systemJournal of Structural Biology, 2005